Congratulations to our longstanding client, Enlivex Therapeutics Ltd. (“Enlivex”, NASDAQ: ENLV), which recently announced the successful completion of a $51.3 million offering of its Ordinary Shares. Leading the transaction on behalf of GT are Bob Grossman, Chair of Greenberg Traurig’s Israel Practice and senior M&A and financing attorney at the firm’s Miami office…